ACUTE LEUKEMIAS XVII
Biology and Treatment Strategies

Munich, Germany - February 24-27, 2019

International Symposium

Registration

Thank you for attending ISALXVII 2019. To facilitate the planning of your stay, please find below all necessary information regarding registration and payment options.

 

REGISTRATION TYPES:

Registration all days (Feb 24-27, 2019)
"Early" registration fee: € 210
Registration and Payment before December 31, 2018
"Advance" registration fee: € 250
Registration and Payment: after January 1, 2019, but before February 22, 2019
On-site registration fee: € 290
Registration after February 22, 2019 or on-site

Registration day ticket: € 80
Sunday, Feb 24, 2019 to Tuesday, Feb 26, 2019

Registration half-day ticket: € 50
Wednesday, Feb 27, 2019

(The registration includes admission to all scientific sessions, the reception on Sunday evening, February 24, 2019, and the Abstract Booklet)

 

PAYMENT OPTIONS:

There are the following options to pay your registration fee either as advance payment or on-site payment.

Advance payment:
Advance payment can be made by check, money order or bank transfer to the ISALXVII account:
Account Holder: Verein für Leukämieforschung e.V.
Bank: Sparkasse Münsterland Ost,
IBAN: DE 64400 501 5000 1900 2468
BIC-Code: WELADED1MST

Please provide following additional details:
- Name of the registered participant plus
- Key word: ACUTE LEUKEMIAS XVII - 2019 

On-site payment:
On-Site payment can only be made cash or by check. Please note that on-site payment by credit card is not possible!

 

SPECIAL TERMS:

FREE ACCESS TO ALL SESSIONS:

  • Invited Speakers and Faculty (As part of the official program, a registration is not required)
  • Members of the Scientific Committees
  • Participating Members of the AMLCG Study Group
  • Members of the LMU and TUM Munich
  • Members of the HelmholtzZentrum Munich
  • Members of the TZM Project Group "Akute Leukämie, MDS und MPS"
  • Former Members of the SFB 684 Munich
  • Students and Nurses (confirmation required)
  • Invited Representatives of the Participating Corporate Partners (confirmation required)